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Abstract
Ergogenic (pharmacological and nutritional) aids in sport, such as immunomodulators 
would be useful for reducing the harmful effects of muscle injury and inflammation,as 
well as in statees of fatigue. These aids, on accelerating the recovery process, could be 
important for improving performance by preventing damaging responses to exhausting 
exercise and modulating the homeostatic adaption processes which lead to recovery and 
remodelling. With the use of these aids, the increase in training load that could be 
tolerated by athletes, which would also be very beneficial for their performance, is also 
an important aspect to consider, as well as mechanisms to preserve the health of the 
athlete.
Finally, remember that these extra requirements should be evaluated and recommended 
by a suitable professional.
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Los inmunomodulares frente a la inflamación y daño muscular originados 
por el ejercicio
Resumen
La utilización de ayudas ergogénicas (farmacológicas y nutricionales) en el deporte, como 
los inmunomoduladores, está indicada para reducir los efectos nocivos del daño muscular 
y la inflamación producidos por el ejercicio intenso, acompañados de un estado de fatiga. 
Estas ayudas, al acelerar el proceso de recuperación, son importantes para mejorar el 
rendimiento mediante la prevención de las respuestas perjudiciales frente a ejercicio 
extenuante modulando los procesos homeostáticos de adaptación que conducen a la re-
cuperación y remodelación muscular. Con el uso de estas ayudas, se produciría un aumen-
to de la carga de entrenamiento que podría ser tolerado por los deportistas. Esto, ade-
más de ser beneficioso para su rendimiento competitivo, también es un elemento 
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Introduction
Exercise-induced muscle damage and its clinical corollary 
(delayed onset on muscular soreness, DOMS) often occur 
due to the predominance of eccentric exercise. The injury 
itself is a mechanical disturbance of the sarcomeres 
provoked by an inflammatory response1-6. PGE2 is the direct 
cause of the pain, whereas leukotrienes increase the 
vascular permeability and attract neutrophils to the site of 
the damage. Together, these two factors result in the feeling 
of inflammation felt by the sportsperson after a hard 
training session7. In contrast, the other type of muscle 
inflammation commonly found in high performance 
sportspeople, which results from cumulative muscle 
damage, occurs 1-2 days after a heavy exercise session and/
or competition, particularly those exercises with a high 
eccentric component in the muscle action, or as a result of 
muscle overuse, is related to DOMS1,7,8.
The effects of exercise on immune function
Intense and acute physical exercise is accompanied by 
responses which are in many ways very similar to those 
induced by infection, sepsis or trauma7. The size of the 
increase in the number of circulating leukocytes (mainly 
lymphocytes and neutrophils) which occurs is related to 
both the intensity and length of the exercise. Increases are 
also found in the plasma concentrations of various substances 
which affect the function of leukocytes, including 
inflammatory cytokines such as TNF- α, the inflammatory 
macrophages protein-1 and IL-1, the anti-inflammatory 
cytokines IL-6 and IL-10 and IL-1 receptor antagonist (IL-
1ra), as well as acute-phase proteins, including C-reactive 
protein (CRP). Indeed, it has been shown that even a 
relatively small increase in the plasma levels of IL-6 leads 
to an increase in the levels of the anti-inflammatory 
cytokines IL-1ra and IL-10 and in CRP. The increase in IL-6 
levels during exercise precedes that of these two cytokines, 
thereby suggesting that IL-6 may initiate this response 
(Figure 1).
Local inflammatory responses
Eccentric contraction-induced muscle damage attracts 
leukocytes to the site of the injury. Neutrophils invade the 
skeletal muscle over several hours (4 h) and remain present 
for up to 24 h post-exercise2,9-11. The neutrophils and 
macrophages help to degrade the damaged muscle by 
releasing reactive oxygen and nitrogen species12, although 
they may also produce proinflammatory cytokines11,12. The 
proinflammatory cytokines interleukin (IL)-1β and tumour 
necrosis factor (TNF)-α are expressed in the muscle for up 
to 5 days post-exercise13,14. IL-1β and TNF-α play a role in 
initiating the destruction of the damaged muscle tissue13,14. 
Other cytokines, such as IL-6 and transforming growth 
factor (TGF)-β1, and inflammatory antigens, such as 
leukemia inhibitory factor (LIF) and hypoxia-inducible 
factor (HIF)-1β are also expressed in muscle in the days 
following eccentric exercise13,15. The local inflammatory 
response in skeletal muscle after eccentric exercise is 
therefore mainly proinflammatory.
Systemic inflammatory responses 
Numerous studies have analysed the changes in the 
concentration of systemic cytokines after eccentric 
exercise, therefore here we will only summarise the 
findings as regards the response of systemic cytokines to 
various types of eccentric exercise16,17. Running at an 
intensity of ≥75% VO2max results in a greater increase in the 
plasma concentrations of IL-6, IL-1 and IL-1ra than other 
forms of eccentric exercise. This difference appears to be 
related to the intensity and length of the exercise and 
possibly to the temperature increase at the site of the 
muscle damage9,17.
Furthermore, it should also be noted that a strong anti-
inflammatory immune reaction, which affects the 
concentration of both pro- and anti-inflammatory cytokines, 
occurs after eccentric exercise9,18. Anti-inflammatory 
cytokines, such as IL-4, IL-13, IL-1ra and IL-10, and soluble 
importante a considerar como mecanismos para preservar la salud del deportista. Por 
último recordar que estos requerimientos extras deberán ser evaluados y recomendados 
por un profesional idóneo.
© 2010 Consell Català de l’Esport. Generalitat de Catalunya. Publicado por Elsevier 
España, S.L. Todos los derechos reservados.
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Figura 1 Cytokine response to exercise.
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TNF-  receptors appear to be produced in the immune 
system’s mononuclear cells19,20. Thus, although the 
proinflammatory responses occur within the muscles after 
eccentric exercise, the release of proinflammatory cytokines 
into the bloodstream also appears to be inhibited. The 
mechanism governing this inhibition is not yet clear, 
although a study by Petersen et al20 appears to suggest the 
involvement of IL-6. Thus, these authors suggest that IL-6 
acts indirectly to restrict the inflammation by stimulating 
the production of anti-inflammatory cytokines, including IL-
1ra, IL-10, cortisol and soluble TNF- α receptor20. The 
plasma concentrations of TNF- α (2.3×), IL-1β (2.1×), IL-6 
(128×) and IL-10 (27×), for example, increase immediately 
after running a marathon, whereas the increases in soluble 
TNF-α receptor (~2×) and IL-1ra (39×) concentration occur 
1-1.5 hours later21. Eccentric exercise therefore also results 
in an increase in circulating anti-inflammatory cytokines in 
response to the local production of proinflammatory 
cytokines to limit the systemic inflammation.
Physical exercise therefore affects both the cellular and 
humoral functions of the immune system. Physical exercise 
also results in an increase in the number of T and B 
lymphocytes, and a decrease in the T helper/T suppressor 
(CD4/CD8) ratio7. The changes to the NK cells depend on 
the intensity and duration of the exercise, and are more 
pronounced after long periods of exercise than after shorter 
ones12.
In this scenario of cell demand and stress, an attraction 
between inflammatory cells in them muscle tissue occurs 
(Figure 2). Due to the global nature of the immune system, 
these localised changes have significant repercussions on 
the lymphocytes and accessory cells outside the muscle 
tissue22, characterising the exercise-induced inflammatory 
response and resulting in leukocyte infiltration and the 
production of proinflammatory cytokines9,23. Furthermore, 
in a broader manifestation of the systemic effects of 
exercise-induced muscle damage and inflammation, it 
should be noted that a state of immunosuppression known 
as “open window”, which is characterised by a decrease in 
natural killer (NK) cell activity, neutrophil function, T and B 
lymphocytes and the concentration of IgA in saliva, and 
which can last for up to 24 hours after completion of the 
exercise, is produced after an intense and prolonged 
exercise session24-28. The seriousness of the damage and the 
length of time during which the symptoms persist depend 
on the specific characteristics of the exercise and factors 
inherent to the individual.
Immunomodulators
Ergogenic aid is defined as any substance or phenomenon 
which improves performance. In this review we concentrate 
on the role of immunomodulatory drugs such as 
glycophosphopeptical (AM3) and a nutritional factor 
known to play an immunomodulatory role, namely 
glutamine.
Exercise-induced muscle damage and inflammation lead 
to changes and imbalances in the immunological system 
along with an “acute phase response”. As discussed above, 
the level of proinflammatory cytokines increases both 
during and after intense exercise. These and other cytokines 
mediate a wide range of metabolic events which affect all 
organ systems in the body9,20,21,29.
The immunomodulators considered to be active in the 
prevention of, or recovery from, the immune system 
alterations associated with competitive sporting activity 
include immunoglobulins, glycophosphopeptical and 
glutamine, a non-essential amino acid which is nevertheless 
important for muscle recovery and regeneration7,8,30,31.
No
Neutrophil, platelet, macrophage 
and lymphocyte recruitmentEndothelial activation
Proinflammatory cytokine Lipid mediatorsPlasma proteasesPeptides
Resolving the inflammation, repair 
of the damage, angiogenesis Chronic inflammation
Removal of stimulus
Exercise
Tissue damage
Yes
Figura 2 Mechanisms in the inflammation triggered by exercise.
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Glycophosphopeptical (AM3)
AM3 is a commercially available immunomodulator with a 
low toxicity profile whose active ingredient is a 
polysaccharide with a complex structure, namely purified 
Candida utilis protein, which has a wide range of regulatory 
effects on innate and adaptive immunity in both mice and 
humans32,33.
AM3 partially inhibits the production of tumour necrosis 
factor (TNF- α) and modulates the production of regulatory 
cytokines (IL-1, IL-2, IL-12)32. Taken together, these 
alterations result in an overall anti-inflammatory effect. We 
have recently shown that AM3 can also reduce and normalise 
the blood concentration of muscle enzymes during intense 
and prolonged competitive sport8,31. This biochemical effect 
is associated with a reduction in proinflammatory cytokine 
levels. AM3 also has other immunomodulatory effects, such 
as stimulating macrophages and NK activity, both of which 
could be beneficial in elite sportspeople, who are more 
susceptible to infection as a result of chronic exercise- and 
stress-related immunosuppression30,31,33. Our study clearly 
showed that AM3 can prevent exercise-induced increases in 
blood IL-6 levels (cycle race, measured 4 hours after the 
race)31. Furthermore, training prior to competition is 
associated with a reduction in soluble TNF receptor levels, 
whereas the competition itself generated a significant 
increase in these levels, albeit with no concomitant increase 
in TNF- α. This immunomodulator could therefore be 
important for prevention of the immunological imbalances 
and tissue damage associated with intense sporting activity. 
The use of these drugs could therefore limit the metabolic, 
muscular and immunological alterations associated with 
prolonged and intense physical exercise (Figure 3 A and B).
Glutamine
Glutamine is a non-essential amino acid which promotes 
muscle growth and reduces exercise-induced 
immunodepression34. Skeletal muscle is the tissue most 
involved in glutamine production, which affects glutamine 
supply to the immune system, therefore skeletal muscle 
activity can directly affect the immune system. Glutamine 
levels in plasma increase after short-term exercise but 
decrease after prolonged and demanding exercise35,36, thus 
suggesting the hypothesis that this reduction in glutamine 
availability could damage immune function. Glutamine is 
one of the main stimulators of heat shock protein (HSP), a 
complex which protects cells against certain types of 
damage37. Indeed, a recent review by Wischmeyer38 proposed 
several interesting concepts regarding HSP, especially that 
glutamine could regulate these cell-protection proteins.
Very intense and prolonged training periods are associated 
with a chronic decrease in the plasma concentration of 
glutamine, and it has been suggested that this reduction 
could be partly responsible for the immunodepression found 
in many resistance athletes37. The intramuscular 
concentration of glutamine is known to be related to the 
nett protein synthesis rate39 However, the mechanisms 
underlying these purported anabolic effects of glutamine 
remain to be determined. It is believed that glutamine 
reduces and attenuates the cytokine response, probably via 
NF-κB, in other words it modulates the inflammatory 
stimulus. 
Intense physical exercise can reduce the release of 
glutamine from skeletal muscle and/or increase the 
absorption of glutamine by other organs or tissues which 
use it (liver, kidneys), thereby limiting the availability of 
glutamine for immune system cells40. Glutamine neutralises 
the catabolic, or cell-tissue destruction, effect caused by 
stress. Stress, particularly exercise-induced stress, results 
in an increase in blood cortisol levels, which causes 
protolysis of the muscle proteins and increased glutamine 
release40. Glutamine plays a key role in muscle recovery, 
increase of muscle mass, force and recovery41. Furthermore, 
an increase in L-alanine, L-citrulline, L-histidine and 
L-arginine levels has been observed after the administration 
of L-glutamine as well as an increase in branched-chain 
amino acids (BCAAs), which facilitates absorption by the 
muscles and the recovery and growth of new muscle fibres42. 
Parry-Billings et al43 have shown (in vitro) that a reduction 
in glutamine levels to below 600 mmol/L is associated with 
a reduction in the synthesis of RNA, the production of IL-2, 
the synthesis of immunoglobulin and in the proliferative 
response of lymphocytes to mitogens, as well as a reduced 
rate of phagocytosis in macrophages.
In light of the above, and in order not to prolong the 
discussion of this topic, it appears clear that glutamine 
helps to maintain a good state of health (Table 1). The 
consumption of glutamine supplements could therefore be 
14
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Figura 3 A) Changes in IL-6; B) TNF- α after a mountain stage 
in professional cyclists treated with AM3 for 90 days.
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beneficial in preventing post-exercise immunodepression 
and for its possible role in promoting anabolic processes, 
including muscular glycogen and protein synthesis, although 
Antonio et al44 have reported that short-term glutamine 
intake does not improve performance in trained male 
weightlifters, thus suggesting its long-term indication. 
However, there is ample evidence to show that prolonged 
periods of intense exercise result in decreased blood 
glutamine levels, which are associated with fatigue, 
overtraining and other catabolic states. In this sense, 
Agostini and Biolo45 have reported that the reduced post-
exercise bioavailability of glutamine could mean that 
glutamine can be considered to be a marker of overtraining. 
An appropriate availability of glutamine could reduce 
inflammation and increase the health benefits associated 
with optimal training. Glutamine supplementation could 
therefore improve systemic immunocompetence.
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